サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1565149

神経補綴の世界市場

Neuroprosthetics

出版日
ページ情報
英文 193 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
神経補綴の世界市場
出版日: 2024年10月04日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 193 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

神経補綴の世界市場は2030年までに252億米ドルに達する見込み

2023年に114億米ドルと推定される神経補綴の世界市場は、分析期間2023-2030年にCAGR 12.0％で成長し、2030年には252億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである運動ニューロン障害アプリケーションは、CAGR13.5%を記録し、分析期間終了時には158億米ドルに達すると予測されます。認知障害アプリケーション分野の成長率は、分析期間中CAGR 10.9%と推定されます。

米国市場は30億米ドルと推定、中国はCAGR 10.9％で成長予測

米国の神経補綴市場は2023年に30億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに38億米ドルの市場規模に達すると予測され、分析期間2023-2030年のCAGRは10.9%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ11.1％と9.9％と予測されています。欧州では、ドイツがCAGR 8.2%で成長すると予測されています。

世界の神経補綴市場- 主要動向と促進要因まとめ

神経補綴とは何か、なぜ変革をもたらすのか？

神経補綴は、神経系とのインターフェースを持ち、怪我や病気、先天性疾患によって失われた神経機能を回復または強化する先進医療機器です。これらの装置は、神経系の特定の領域に電気信号を送ることにより、運動制御、感覚知覚、さらには認知機能などの機能を代替または補助することができます。神経補綴の一般的な例としては、聴覚回復のための人工内耳、パーキンソン病のための脳深部刺激（DBS）装置、麻痺のある人がロボットの手足を操作できるようにするブレイン・マシン・インターフェースなどがあります。

神経補綴の変革的性質は、重度の障害を持つ人々の自立を回復し、生活の質を向上させる能力にあります。これらのデバイスは、てんかん、脳卒中、脊髄損傷など、幅広い神経疾患の治療に新たな可能性をもたらしました。神経補綴技術の進歩が進むにつれて、リアルタイムで脳と相互作用できる、より洗練されたシステムを開発する可能性が現実のものとなりつつあり、世界中の何百万人もの患者に新たな希望をもたらしています。

神経補綴市場はどのように進化しているか？

神経補綴市場は、材料科学、神経科学、生物工学の進歩により、急速に進化しています。この市場で最も重要な動向のひとつは、外部ワイヤーやかさばるハードウェアを必要としないワイヤレス神経補綴システムの開発です。このようなワイヤレス・デバイスは、患者にとってより大きな可動性と快適性を提供すると同時に、有線システムに関連する感染リスクを低減します。さらに、神経補綴部品の小型化により、身体とのシームレスな統合が可能になり、機器の機能性と審美性の両方が向上しています。

もうひとつの重要な動向は、神経補綴における機械学習とAIの利用の増加です。AIアルゴリズムを組み込むことで、これらの機器は患者の神経パターンから学習し、特定のニーズに適応することができ、よりパーソナライズされた効果的な治療を提供することができます。これは、ロボット手足などの外部機器を制御するために脳信号のリアルタイム分析に依存するブレイン・コンピュータ・インターフェイス（BCI）にとって特に重要です。AI技術の進歩に伴い、神経補綴はより直感的で応答性の高いものとなり、患者の生活への影響をさらに高めることが期待されます。

神経補綴の普及を促進する疾患は？

いくつかの神経疾患が神経補綴の採用を促進しており、中でも難聴、パーキンソン病、麻痺が顕著です。最も広く使用されている神経補装具である人工内耳は、重度の聴覚障害を持つ何百万人もの人が聴力を取り戻すのに役立っています。これらの装置は、耳の損傷部分をバイパスして聴覚神経を直接刺激し、音の信号が脳に到達するための明確な経路を提供します。

パーキンソン病の治療では、脳深部刺激（DBS）装置が振戦や硬直などの運動症状をコントロールする手段を提供することで、患者の治療に革命をもたらしました。DBS装置は脳の特定部位に電気インパルスを送り、異常な神経活動を制御します。同様に、脊髄損傷や麻痺のための神経補装具も普及しつつあります。これらの装置は、しばしばブレイン・コンピュータ・インターフェイスと組み合わされ、麻痺患者が自分の思考を使ってロボットの手足や外骨格を操作することを可能にし、以前は実現不可能だったレベルの可動性を回復させる。

神経補綴市場の主な成長促進要因は？

神経補綴市場の成長は、いくつかの要因によってもたらされます。主な要因の1つは、難聴、てんかん、パーキンソン病、脊髄損傷などの神経疾患の有病率の増加です。世界人口の高齢化に伴い、これらの疾患の罹患率が上昇し、神経補綴ソリューションの需要が高まることが予想されます。また、材料、AI、生体工学の技術進歩が急速に進んでおり、神経補綴がより効果的で快適なものとなり、より多くの患者が利用できるようになっていることも大きな推進力となっています。

また、個別化医療への注目の高まりも市場を後押ししており、神経人工装具が個々の患者の特定のニーズに合わせて調整されるようになってきています。さらに、神経学的研究開発への投資の増大と医療機器に対する良好な規制環境が、技術革新と市場拡大の機会を生み出しています。神経補綴研究、特にブレイン・コンピュータ・インターフェイスに対する公的・民間資金の増加は、この市場の成長をさらに加速させています。

調査対象企業の例（注目の44社）

  • Abbott Laboratories
  • Boston Scientific Corporation
  • Cochlear Ltd.
  • LivaNova PLC
  • Medtronic PLC
  • NDI Medical
  • NeuroPace, Inc.
  • Nevro Corp.
  • Retina Implant AG
  • Second Sight Medical Products, Inc.
  • Sonova Holding AG

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • その他の地域

第4章 競合

目次
Product Code: MCP13580

Global Neuroprosthetics Market to Reach US$25.2 Billion by 2030

The global market for Neuroprosthetics estimated at US$11.4 Billion in the year 2023, is expected to reach US$25.2 Billion by 2030, growing at a CAGR of 12.0% over the analysis period 2023-2030. Motor Neuron Disorders Application, one of the segments analyzed in the report, is expected to record a 13.5% CAGR and reach US$15.8 Billion by the end of the analysis period. Growth in the Cognitive Disorders Application segment is estimated at 10.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$3.0 Billion While China is Forecast to Grow at 10.9% CAGR

The Neuroprosthetics market in the U.S. is estimated at US$3.0 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$3.8 Billion by the year 2030 trailing a CAGR of 10.9% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 11.1% and 9.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 8.2% CAGR.

Global Neuroprosthetics Market - Key Trends & Drivers Summarized

What Are Neuroprosthetics and Why Are They Transformative?

Neuroprosthetics are advanced medical devices that interface with the nervous system to restore or enhance neurological functions that have been lost due to injury, disease, or congenital conditions. These devices can replace or assist functions such as motor control, sensory perception, and even cognitive functions by sending electrical signals to specific areas of the nervous system. Common examples of neuroprosthetics include cochlear implants for hearing restoration, deep brain stimulation (DBS) devices for Parkinson’s disease, and brain-machine interfaces that enable paralyzed individuals to control robotic limbs.

The transformative nature of neuroprosthetics lies in their ability to restore independence and improve the quality of life for individuals with severe disabilities. These devices have opened new possibilities in treating a wide range of neurological disorders, including epilepsy, stroke, and spinal cord injuries. As advancements in neuroprosthetic technology continue, the potential for developing more sophisticated systems that can interact with the brain in real-time is becoming a reality, offering new hope to millions of patients worldwide.

How Is the Neuroprosthetics Market Evolving?

The neuroprosthetics market is evolving rapidly, driven by advances in materials science, neuroscience, and bioengineering. One of the most significant trends in this market is the development of wireless neuroprosthetic systems that eliminate the need for external wires or bulky hardware. These wireless devices provide greater mobility and comfort for patients, while also reducing the risk of infection associated with wired systems. Additionally, the miniaturization of neuroprosthetic components has enabled more seamless integration with the body, improving both the functionality and aesthetic appeal of the devices.

Another key trend is the increasing use of machine learning and AI in neuroprosthetics. By incorporating AI algorithms, these devices can learn from a patient's neural patterns and adapt to their specific needs, providing more personalized and effective treatment. This is particularly important for brain-computer interfaces (BCIs), which rely on real-time analysis of brain signals to control external devices such as robotic limbs. As AI technology continues to advance, neuroprosthetics are expected to become more intuitive and responsive, further enhancing their impact on patients’ lives.

Which Conditions Are Driving Neuroprosthetic Adoption?

Several neurological conditions are driving the adoption of neuroprosthetics, with the most prominent being hearing loss, Parkinson’s disease, and paralysis. Cochlear implants, the most widely used neuroprosthetic devices, have helped millions of individuals with severe hearing impairments regain the ability to hear. These devices work by bypassing damaged parts of the ear and directly stimulating the auditory nerve, providing a clear path for sound signals to reach the brain.

In the treatment of Parkinson’s disease, deep brain stimulation (DBS) devices have revolutionized patient care by providing a means of controlling motor symptoms such as tremors and rigidity. DBS devices send electrical impulses to specific areas of the brain to regulate abnormal neural activity. Similarly, neuroprosthetic devices for spinal cord injuries and paralysis are gaining traction. These devices, often coupled with brain-computer interfaces, enable paralyzed patients to control robotic limbs or exoskeletons using their thoughts, restoring a level of mobility that was previously unattainable.

What Are the Key Growth Drivers in the Neuroprosthetics Market?

The growth in the neuroprosthetics market is driven by several factors. One of the primary drivers is the increasing prevalence of neurological disorders, including hearing loss, epilepsy, Parkinson’s disease, and spinal cord injuries. As the global population ages, the incidence of these conditions is expected to rise, driving demand for neuroprosthetic solutions. Another major driver is the rapid pace of technological advancements in materials, AI, and bioengineering, which are making neuroprosthetics more effective, comfortable, and accessible to a broader patient population.

The expanding focus on personalized medicine is also pushing the market forward, as neuroprosthetic devices are increasingly being tailored to meet the specific needs of individual patients. Additionally, the growing investments in neurological research and development, along with favorable regulatory environments for medical devices, are creating opportunities for innovation and market expansion. The rise in public and private funding for neuroprosthetic research, particularly in brain-computer interfaces, is further accelerating the growth of this market.

Select Competitors (Total 44 Featured) -

  • Abbott Laboratories
  • Boston Scientific Corporation
  • Cochlear Ltd.
  • LivaNova PLC
  • Medtronic PLC
  • NDI Medical
  • NeuroPace, Inc.
  • Nevro Corp.
  • Retina Implant AG
  • Second Sight Medical Products, Inc.
  • Sonova Holding AG

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Neuroprosthetics - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Growing Incidence of Neurological Disorders and Disabilities Drives Demand for Neuroprosthetic Devices
    • Advancements in Brain-Computer Interface (BCI) Technology Propel Growth in Neuroprosthetics for Motor Function Rehabilitation
    • Rising Adoption of Cochlear Implants and Auditory Neuroprosthetics Expands Market in Hearing Restoration Applications
    • Increasing Use of Neuroprosthetics for Deep Brain Stimulation (DBS) Strengthens Business Case for Parkinsons and Epilepsy Treatment
    • Growing Integration of AI and Machine Learning in Neuroprosthetics Fuels Innovation in Personalized Rehabilitation Therapies
    • Surge in Demand for Retinal Implants and Visual Neuroprosthetics Expands Opportunities in Vision Restoration Technologies
    • Technological Advancements in Wireless Neuroprosthetics Drive Growth in Wearable and Portable Devices for Neurological Patients
    • Increasing Use of Neuroprosthetics in Spinal Cord Injury Rehabilitation Spurs Demand for Advanced Neural Interface Devices
    • Emerging Focus on Peripheral Nerve Stimulation in Neuroprosthetics Expands Applications in Pain Management and Neuroplasticity
    • Rising Adoption of Neuroprosthetics in the Treatment of Epilepsy and Tremors Expands Market for Brain Stimulation Devices
    • Growing Interest in Neuroprosthetic Solutions for Stroke Recovery Drives Innovation in Brain-Machine Interfaces for Motor Function Restoration
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Neuroprosthetics Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Neuroprosthetics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 3: World 7-Year Perspective for Neuroprosthetics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Motor Neuron Disorders by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 5: World 7-Year Perspective for Motor Neuron Disorders by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for Cognitive Disorders by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 7: World 7-Year Perspective for Cognitive Disorders by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Physiological Disorders by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 9: World 7-Year Perspective for Physiological Disorders by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Spinal Cord Stimulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 11: World 7-Year Perspective for Spinal Cord Stimulation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 12: World Recent Past, Current & Future Analysis for Deep Brain Stimulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 13: World 7-Year Perspective for Deep Brain Stimulation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Vagus Nerve Stimulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 15: World 7-Year Perspective for Vagus Nerve Stimulation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Sacral Nerve Stimulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 17: World 7-Year Perspective for Sacral Nerve Stimulation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030
    • TABLE 18: World Recent Past, Current & Future Analysis for Transcranial Magnetic Stimulation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 19: World 7-Year Perspective for Transcranial Magnetic Stimulation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Neuroprosthetics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 20: USA Recent Past, Current & Future Analysis for Neuroprosthetics by Application - Motor Neuron Disorders, Cognitive Disorders and Physiological Disorders - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 21: USA 7-Year Perspective for Neuroprosthetics by Application - Percentage Breakdown of Value Sales for Motor Neuron Disorders, Cognitive Disorders and Physiological Disorders for the Years 2024 & 2030
    • TABLE 22: USA Recent Past, Current & Future Analysis for Neuroprosthetics by Technique - Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation and Transcranial Magnetic Stimulation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 23: USA 7-Year Perspective for Neuroprosthetics by Technique - Percentage Breakdown of Value Sales for Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation and Transcranial Magnetic Stimulation for the Years 2024 & 2030
  • CANADA
    • TABLE 24: Canada Recent Past, Current & Future Analysis for Neuroprosthetics by Application - Motor Neuron Disorders, Cognitive Disorders and Physiological Disorders - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 25: Canada 7-Year Perspective for Neuroprosthetics by Application - Percentage Breakdown of Value Sales for Motor Neuron Disorders, Cognitive Disorders and Physiological Disorders for the Years 2024 & 2030
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Neuroprosthetics by Technique - Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation and Transcranial Magnetic Stimulation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 27: Canada 7-Year Perspective for Neuroprosthetics by Technique - Percentage Breakdown of Value Sales for Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation and Transcranial Magnetic Stimulation for the Years 2024 & 2030
  • JAPAN
    • Neuroprosthetics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 28: Japan Recent Past, Current & Future Analysis for Neuroprosthetics by Application - Motor Neuron Disorders, Cognitive Disorders and Physiological Disorders - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 29: Japan 7-Year Perspective for Neuroprosthetics by Application - Percentage Breakdown of Value Sales for Motor Neuron Disorders, Cognitive Disorders and Physiological Disorders for the Years 2024 & 2030
    • TABLE 30: Japan Recent Past, Current & Future Analysis for Neuroprosthetics by Technique - Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation and Transcranial Magnetic Stimulation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 31: Japan 7-Year Perspective for Neuroprosthetics by Technique - Percentage Breakdown of Value Sales for Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation and Transcranial Magnetic Stimulation for the Years 2024 & 2030
  • CHINA
    • Neuroprosthetics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 32: China Recent Past, Current & Future Analysis for Neuroprosthetics by Application - Motor Neuron Disorders, Cognitive Disorders and Physiological Disorders - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: China 7-Year Perspective for Neuroprosthetics by Application - Percentage Breakdown of Value Sales for Motor Neuron Disorders, Cognitive Disorders and Physiological Disorders for the Years 2024 & 2030
    • TABLE 34: China Recent Past, Current & Future Analysis for Neuroprosthetics by Technique - Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation and Transcranial Magnetic Stimulation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 35: China 7-Year Perspective for Neuroprosthetics by Technique - Percentage Breakdown of Value Sales for Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation and Transcranial Magnetic Stimulation for the Years 2024 & 2030
  • EUROPE
    • Neuroprosthetics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 36: Europe Recent Past, Current & Future Analysis for Neuroprosthetics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 37: Europe 7-Year Perspective for Neuroprosthetics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2024 & 2030
    • TABLE 38: Europe Recent Past, Current & Future Analysis for Neuroprosthetics by Application - Motor Neuron Disorders, Cognitive Disorders and Physiological Disorders - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Europe 7-Year Perspective for Neuroprosthetics by Application - Percentage Breakdown of Value Sales for Motor Neuron Disorders, Cognitive Disorders and Physiological Disorders for the Years 2024 & 2030
    • TABLE 40: Europe Recent Past, Current & Future Analysis for Neuroprosthetics by Technique - Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation and Transcranial Magnetic Stimulation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 41: Europe 7-Year Perspective for Neuroprosthetics by Technique - Percentage Breakdown of Value Sales for Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation and Transcranial Magnetic Stimulation for the Years 2024 & 2030
  • FRANCE
    • Neuroprosthetics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 42: France Recent Past, Current & Future Analysis for Neuroprosthetics by Application - Motor Neuron Disorders, Cognitive Disorders and Physiological Disorders - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 43: France 7-Year Perspective for Neuroprosthetics by Application - Percentage Breakdown of Value Sales for Motor Neuron Disorders, Cognitive Disorders and Physiological Disorders for the Years 2024 & 2030
    • TABLE 44: France Recent Past, Current & Future Analysis for Neuroprosthetics by Technique - Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation and Transcranial Magnetic Stimulation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: France 7-Year Perspective for Neuroprosthetics by Technique - Percentage Breakdown of Value Sales for Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation and Transcranial Magnetic Stimulation for the Years 2024 & 2030
  • GERMANY
    • Neuroprosthetics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 46: Germany Recent Past, Current & Future Analysis for Neuroprosthetics by Application - Motor Neuron Disorders, Cognitive Disorders and Physiological Disorders - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 47: Germany 7-Year Perspective for Neuroprosthetics by Application - Percentage Breakdown of Value Sales for Motor Neuron Disorders, Cognitive Disorders and Physiological Disorders for the Years 2024 & 2030
    • TABLE 48: Germany Recent Past, Current & Future Analysis for Neuroprosthetics by Technique - Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation and Transcranial Magnetic Stimulation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 49: Germany 7-Year Perspective for Neuroprosthetics by Technique - Percentage Breakdown of Value Sales for Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation and Transcranial Magnetic Stimulation for the Years 2024 & 2030
  • ITALY
    • TABLE 50: Italy Recent Past, Current & Future Analysis for Neuroprosthetics by Application - Motor Neuron Disorders, Cognitive Disorders and Physiological Disorders - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Italy 7-Year Perspective for Neuroprosthetics by Application - Percentage Breakdown of Value Sales for Motor Neuron Disorders, Cognitive Disorders and Physiological Disorders for the Years 2024 & 2030
    • TABLE 52: Italy Recent Past, Current & Future Analysis for Neuroprosthetics by Technique - Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation and Transcranial Magnetic Stimulation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 53: Italy 7-Year Perspective for Neuroprosthetics by Technique - Percentage Breakdown of Value Sales for Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation and Transcranial Magnetic Stimulation for the Years 2024 & 2030
  • UNITED KINGDOM
    • Neuroprosthetics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 54: UK Recent Past, Current & Future Analysis for Neuroprosthetics by Application - Motor Neuron Disorders, Cognitive Disorders and Physiological Disorders - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 55: UK 7-Year Perspective for Neuroprosthetics by Application - Percentage Breakdown of Value Sales for Motor Neuron Disorders, Cognitive Disorders and Physiological Disorders for the Years 2024 & 2030
    • TABLE 56: UK Recent Past, Current & Future Analysis for Neuroprosthetics by Technique - Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation and Transcranial Magnetic Stimulation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: UK 7-Year Perspective for Neuroprosthetics by Technique - Percentage Breakdown of Value Sales for Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation and Transcranial Magnetic Stimulation for the Years 2024 & 2030
  • REST OF EUROPE
    • TABLE 58: Rest of Europe Recent Past, Current & Future Analysis for Neuroprosthetics by Application - Motor Neuron Disorders, Cognitive Disorders and Physiological Disorders - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 59: Rest of Europe 7-Year Perspective for Neuroprosthetics by Application - Percentage Breakdown of Value Sales for Motor Neuron Disorders, Cognitive Disorders and Physiological Disorders for the Years 2024 & 2030
    • TABLE 60: Rest of Europe Recent Past, Current & Future Analysis for Neuroprosthetics by Technique - Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation and Transcranial Magnetic Stimulation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 61: Rest of Europe 7-Year Perspective for Neuroprosthetics by Technique - Percentage Breakdown of Value Sales for Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation and Transcranial Magnetic Stimulation for the Years 2024 & 2030
  • ASIA-PACIFIC
    • Neuroprosthetics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 62: Asia-Pacific Recent Past, Current & Future Analysis for Neuroprosthetics by Application - Motor Neuron Disorders, Cognitive Disorders and Physiological Disorders - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Asia-Pacific 7-Year Perspective for Neuroprosthetics by Application - Percentage Breakdown of Value Sales for Motor Neuron Disorders, Cognitive Disorders and Physiological Disorders for the Years 2024 & 2030
    • TABLE 64: Asia-Pacific Recent Past, Current & Future Analysis for Neuroprosthetics by Technique - Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation and Transcranial Magnetic Stimulation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 65: Asia-Pacific 7-Year Perspective for Neuroprosthetics by Technique - Percentage Breakdown of Value Sales for Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation and Transcranial Magnetic Stimulation for the Years 2024 & 2030
  • REST OF WORLD
    • TABLE 66: Rest of World Recent Past, Current & Future Analysis for Neuroprosthetics by Application - Motor Neuron Disorders, Cognitive Disorders and Physiological Disorders - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 67: Rest of World 7-Year Perspective for Neuroprosthetics by Application - Percentage Breakdown of Value Sales for Motor Neuron Disorders, Cognitive Disorders and Physiological Disorders for the Years 2024 & 2030
    • TABLE 68: Rest of World Recent Past, Current & Future Analysis for Neuroprosthetics by Technique - Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation and Transcranial Magnetic Stimulation - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Rest of World 7-Year Perspective for Neuroprosthetics by Technique - Percentage Breakdown of Value Sales for Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation and Transcranial Magnetic Stimulation for the Years 2024 & 2030

IV. COMPETITION